Literature DB >> 8014495

Candidacidal activity of macrophages from immunocompetent and congenitally immunodeficient mice.

A Vazquez-Torres1, J Jones-Carson, E Balish.   

Abstract

The chemotactic, phagocytic, and candidacidal activities of peritoneal exudate macrophages from immunocompetent heterozygous (bg/+) and immunodeficient homozygous (bg/bg, bg/bg-nu/+, and bg/bg-nu/nu) beige mice were assessed. Overall, macrophages from all strains of mice tested not only were able to migrate into the peritoneal cavity in response to several eliciting agents but showed a comparable capacity to phagocytize fluorescein isothiocyanate-labeled, heat-killed Candida albicans. However, some populations of peritoneal exudate macrophages from homozygous beige mice (e.g., thioglycollate-elicited) and resident peritoneal macrophages from bg/bg mice incubated in vitro with supernatants from concanavalin A-stimulated splenocytes had poorer candidacidal activity than did control macrophages from bg/+mice. Interferon-gamma enhanced the in vitro candidacidal activity of macrophages from homozygous and heterozygous beige mice. As indicated by inhibitors, poor macrophage candidacidal activity seemed to correlate better with deficient nitric oxide--than with superoxide anion-mediated killing. These data suggest that impaired candidacidal activity of macrophages from homozygous beige mice may explain their enhanced susceptibility to candidiasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014495     DOI: 10.1093/infdis/170.1.180

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.

Authors:  S Mizutani; M Endo; T Ino-Ue; M Kurasawa; Y Uno; H Saito; I Kato; K Takesako
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene.

Authors:  Mathieu Goupil; Emilie Bélanger Trudelle; Véronique Dugas; Catherine Racicot-Bergeron; Francine Aumont; Serge Sénéchal; Zaher Hanna; Paul Jolicoeur; Louis de Repentigny
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

3.  Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.

Authors:  S Elahi; G Pang; R Clancy; R B Ashman
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 4.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

5.  Candida albicans suppresses nitric oxide (NO) production by interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages.

Authors:  T Chinen; M H Qureshi; Y Koguchi; K Kawakami
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

6.  Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin.

Authors:  Edward Balish; Thomas F Warner; Peter J Nicholas; Emily E Paulling; Caroline Westwater; David A Schofield
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Nitric oxide-enhanced resistance to oral candidiasis.

Authors:  S Elahi; G Pang; R B Ashman; R Clancy
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

Review 8.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

9.  Nitric oxide plays a key role in the platelet-activating factor-induced enhancement of resistance against systemic candidiasis.

Authors:  Han-A Kim; So-Hee Kim; Hyun-Mi Ko; Jung-Hwa Choi; Kyoung-Jin Kim; Sin-Hye Oh; Kyoung-Oh Cho; Il-Whan Choi; Suhn-Young Im
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

10.  Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis.

Authors:  G M Winslow; E Yager; K Shilo; D N Collins; F K Chu
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.